ID   8H9 [Mouse hybridoma against human CD276]
AC   CVCL_B0L9
DR   ABCD; ABCD_AH797
DR   Wikidata; Q108819782
RX   Patent=US9938351;
RX   PubMed=11358824;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10926.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized omburtamab potential therapeutic antibody against neuroblastoma.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 6
//
RX   Patent=US9938351;
RA   Cheung N.-K.V.;
RT   "Uses of monoclonal antibody 8H9.";
RL   Patent number US9938351, 10-Apr-2018.
//
RX   PubMed=11358824;
RA   Modak S., Kramer K., Gultekin S.H., Guo H.-F., Cheung N.-K.V.;
RT   "Monoclonal antibody 8H9 targets a novel cell surface antigen
RT   expressed by a wide spectrum of human solid tumors.";
RL   Cancer Res. 61:4048-4054(2001).
//